Scientific Abstract Presentations: Breast Session 12 Sunday, October 30 Sun, Oct 30 3:30-4:30 p.m. EDT
|
|||
|---|---|---|---|
3:30 PM |
The Sensory Assessment after FTM gender affirming mastectomy (SAFTY) Study |
||
3:35 PM |
Comparison of Postoperative Opioid Use in Gender-Affirming Mastectomies, Oncologic Mastectomies, and Gynecomastia Mastectomies
|
||
3:40 PM |
The Nipple-Preserving Inferior Ellipse Mastectomy: A New Technique for Masculinizing Top Surgery |
||
3:45 PM |
Systematic Review of Risk Factors for Hematoma in Gender-Affirming Mastectomy |
||
3:50 PM |
Liposomal Bupivacaine Reduces Intraoperative Narcotic Use in Reduction Mammaplasty Patients |
||
3:55 PM |
The Effects of Connecticut’s Prescription Monitoring Program on Narcotic Prescribing Patterns in Breast Reduction Surgery |
||
4:00 PM |
How Big Is Too Big? Predicting Breast Skin Necrosis Using Clinical Measurements |
||
4:05 PM |
Capsular Contracture Management Following Breast Augmentation: Systematic Review and Best Practices |
||
4:10 PM |
A Cross-sectional Analysis of Preoperative Breast Augmentation Patient Questions: Developing a Predictive Model of Age Groups |
||
4:20 PM |
Breast Session 12 - Discussion 1 |
||
Accreditation: The American Society of Plastic Surgeons® (ASPS) is accredited by the Accreditation Council for Continuing Education to provide continuing medical education for physicians.
Designation: The ASPS designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
*Subject to change